TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial.

Roy S Herbst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.